Axcelis Technologies, Inc.
ACLS
$132.19
$7.465.98%
| Weiss Ratings | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | A+ | |||
| Rating Factors | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Excellent | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.16 | |||
| Price History | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.52% | |||
| 30-Day Total Return | 3.70% | |||
| 60-Day Total Return | 66.57% | |||
| 90-Day Total Return | 77.70% | |||
| Year to Date Total Return | 69.04% | |||
| 1-Year Total Return | 62.90% | |||
| 2-Year Total Return | 253.17% | |||
| 3-Year Total Return | 624.33% | |||
| 5-Year Total Return | 437.36% | |||
| 52-Week High % Change | -8.54% | |||
| 52-Week Low % Change | 168.76% | |||
| Price | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $136.38 | |||
| 52-Week Low Price | $46.41 | |||
| 52-Week Low Price (Date) | Jul 05, 2022 | |||
| 52-Week High Price (Date) | Mar 23, 2023 | |||
| Valuation | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | $4.08B | |||
| Enterprise Value | 3.71B | |||
| Price/Earnings (TTM) | 22.83 | |||
| Earnings Per Share (TTM) | 5.46 | |||
| Earnings Per Share Growth | 88.78% | |||
| Price/Earnings To Growth | 0.26 | |||
| Price/Sales (TTM) | 4.51 | |||
| Price/Book (Q) | 6.13 | |||
| Enterprise Value/Revenue (TTM) | 4.03 | |||
| Price | $132.19 | |||
| Enterprise Value/EBITDA (TTM) | 16.65 | |||
| Enterprise Value/EBIT | 17.46 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 33.262M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 978 787 4000 | |||
| Address | 108 Cherry Hill Drive Beverly, MA 01915-1088 | |||
| Website | www.axcelis.com | |||
| Country | United States | |||
| Year Founded | 1978 | |||
| Profitability | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 23.08% | |||
| Profit Margin | 19.89% | |||
| Management Effectiveness | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 15.02% | |||
| Return on Equity | 30.36% | |||
| Income Statement | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | $920.00M | |||
| Total Revenue (TTM) | $920.00M | |||
| Revenue Per Share | $27.66 | |||
| Gross Profit (TTM) | $401.79M | |||
| EBITDA (TTM) | $222.57M | |||
| EBIT (TTM) | $212.36M | |||
| Net Income (TTM) | $183.08M | |||
| Net Income Avl. to Common (TTM) | $183.08M | |||
| Total Revenue Growth (Q YOY) | 29.35% | |||
| Earnings Growth (Q YOY) | 59.42% | |||
| EPS Diluted (TTM) | $5.46 | |||
| EPS Diluted Growth (Q YOY) | 62.57% | |||
| Balance Sheet | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $432.17M | |||
| Cash Per Share (Q) | $12.99 | |||
| Total Current Assets (Q) | $877.65M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | $667.26M | |||
| Current Ratio (Q) | 3.537 | |||
| Book Value Per Share (Q) | $20.36 | |||
| Total Assets (Q) | $1.01B | |||
| Total Current Liabilities (Q) | $248.13M | |||
| Total Debt (Q) | $58.71M | |||
| Total Liabilities (Q) | $346.39M | |||
| Total Common Equity (Q) | $667.26M | |||
| Cash Flow | ACLS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -$257.25M | |||
| Cash from Financing (TTM) | -$65.48M | |||
| Net Change in Cash (TTM) | -$109.33M | |||
| Levered Free Cash Flow (TTM) | $119.55M | |||
| Cash from Operations (TTM) | $215.61M | |||
